Sentences with phrase «advance regenerative medicine research»

Not exact matches

An original co-founder of MaRS, U of T has chosen the site for its renowned research teams working in drug discovery, regenerative medicine, infectious diseases and advanced computing.

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cRegenerative Medicine & Cell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cell Medicine & Cell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cregenerative medicine and cell medicine and cell therapy.

The multidisciplinary team behind the current study includes world - renowned researchers in the field of regenerative medicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical Universitregenerative medicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inmedicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical UniversitRegenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical UniversitRegenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inResearch Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inresearch team at the Kuban State Medical University in Russia.

«Because of relatively low survival rates and their advancing age, these patients tend to be poor candidates for aggressive therapies, like a bone marrow transplant,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, chief of the Division of Regenerative Medicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores Cancermedicine, chief of the Division of Regenerative Medicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores CancerMedicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores CancerMedicine and director of the Stem Cell Research Program at Moores Cancer Center.

In the field of iPS cell - based regenerative medicine, advanced research with clinical applications for many organs and tissues, such as the retina, has steadily progressed.

UCLA researchers led by Drs. Peiyee Lee and Richard Gatti at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells (iPSC) to advance disease - in - a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia (A-T).

FORT LAUDERDALE / DAVIE, Fla. — Leading faculty members from the Nova Southeastern University (NSU) College of Allopathic Medicine (M.D. College) are scheduled to present their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell SummitMedicine (M.D. College) are scheduled to present their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell Summitmedicine at the 2018 World Stem Cell Summit (WSCS).

The University of California, San Diego (UCSD) Human Stem Cell Core Facility, which supports multiple research projects using stem cells to advance the understanding and ultimately the treatment of disease and injury, will receive a $ 2.8 million Shared Research Laboratory Grant from the California Institute for Regenerative Medicineresearch projects using stem cells to advance the understanding and ultimately the treatment of disease and injury, will receive a $ 2.8 million Shared Research Laboratory Grant from the California Institute for Regenerative MedicineResearch Laboratory Grant from the California Institute for Regenerative Medicine (CIRM).

The Okyanos Center for Regenerative Medicine was founded in 2011 to offer patients the most advanced and safe medical treatments in regenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cRegenerative Medicine was founded in 2011 to offer patients the most advanced and safe medical treatments in regenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cell Medicine was founded in 2011 to offer patients the most advanced and safe medical treatments in regenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cregenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cell medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cell therapy.

Housed in NSU's Center for Collaborative Research, the NSU Cell Therapy Institute focuses on advancing new approaches to cancer immunotherapy and regenerative medicine

An anonymous donor made a $ 100,000 contribution to advance research at the Department of Rehabilitation & Regenerative Medicine.

Organized by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceRegenerative Medicine (ARM), the California Institute for Regenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science intMedicine (ARM), the California Institute for Regenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceRegenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science intMedicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceRegenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science intMedicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceregenerative medicine industry with the scientific research community to advance stem cell science intmedicine industry with the scientific research community to advance stem cell science into cures.

«Our study shows that this unique stem cell - based retinal implant thus far is well - tolerated, and preliminary results suggest it may help people with advanced dry age - related macular degeneration,» says coauthor and lead inventor of the implant Dr. Mark S. Humayun, MD, director of the USC Institute for Biomedical Therapeutics, co-director of the USC Roski Eye Institute, affiliate principal investigator with the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC and university professor of ophthalmology at the Keck School.

Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).

This advance will allow biomedical scientists to study the functioning of an individual's intestinal lining in a controlled microenvironment, where the lining can interact with immune cells, blood cells and drugs, said Robert Barrett, PhD, assistant professor of Medicine and research scientist at the Cedars - Sinai Board of Governors Regenerative Medicine Institute.

Included among the numerous recipients of Mr. Sanford's gifts, that total more than one billion dollars, are: the Edith Sanford Foundation for Breast Cancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mmedicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MMedicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MedicineMedicine.

In May 2008, the consortium, known then as the San Diego Consortium for Regenerative Medicine, received a $ 43 million grant from the California Institute for Regenerative Medicine (CIRM), the state agency established by the people of California in 2004 through approval of Proposition 71, which authorized the disbursement $ 3 billion in funding to advance stem cell research.

The Sanford Consortium for Regenerative Medicine and the Takeda Pharmaceutical Company have established a five - year, $ 10 - million Innovation Alliance to foster scientific collaborations and advance each organization's research missions.

'' Below is recent news about the Institute, our patients, and advances in stem cell research and immune regenerative medicine.»

The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats.

Funding Research reported in this news release was supported by the National Center for Advancing Translational Sciences (award number 1 - UG3 - NS -105703-01) and the National Institute of Diabetes and Digestive and Kidney Diseases (award number R56DK106202 - 01) of the National Institutes of Health: the Cedars - Sinai Board of Governors Regenerative Medicine Institute; the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; and the Drown Foundation.

The Ogawa - Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine.

The mission of Sanford Consortium for Regenerative Medicine is to advance stem cell research through collaborative, multi-disciplinary interactions.

The Broad Foundation has also invested in advancing stem cell research, particularly in California through the creation of the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research research, particularly in California through the creation of the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Research at USC, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Research at UCLA and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Research at UCSF.